RTOG 前列腺癌靶区勾画指南
前列腺癌靶区勾画
Langen KM, et al. IJROBP, 50:265, 2001
前列腺移动产生的位置变化
运动方向
前后方向 两侧方向 上下方向
标准差(SD) 1.5-4.1 mm 0.7-1.9 mm 1.7-4.5 mm
48.9% 36.7%
49.8% 36.5%
0.008 0.48
Roach M, et al, JCO, 21:1904, 2003
盆腔预防照射随机研究(2)
RTOG 94-13:结果
无失败率
全盆腔照射:前列腺照射
新辅助激素:辅助激素治疗
Roach M, et al, JCO, 21:1904, 2003
和平均位置比较
Lat: SD 1.9
20 17
8 7.5
2 5.3 (mean)
6.3 (mean) 10.8 8.8 9.9 13
7
Langen KM, et al. IJROBP, 50:265, 2001
前列腺移动产生的位置变化
膀胱体积、直肠充盈度和 治疗体位影响前列腺位置
前后和上下方向移动较大, 侧位方向移动较小
盆腔预防照射随机研究(2)
RTOG 94-13:结果
高危病人盆腔预防照射改善无病 生存率,但未改善总生存率
新辅助放疗和辅助放疗无差别
Roach M, et al, JCO, 21:1904, 2003
前列腺癌预后分组、靶区和治疗原则
预后好
预后中等
预后不良
定义 Gleason分级 PSA(ng/ml) 分期
26%有包膜外明显浸润 前列腺包膜外浸润平均为2 mm,
范围为0.5-12.0 mm 2.8%的病人超过>5mm
【源版】前列腺癌靶区勾画
ICRU report 62
计划靶区 (PTV)
PTV包括临床靶区本身、照射中患者 器官运动(ITV),和日常摆位、治疗中 靶位置和靶体积变化等因素引起的扩 大照射的组织范围.
PTV决定了照射野的大小
• 血管旁 • 淋巴管和淋巴结旁 • 肌肉间 • 神经 •骨
IMRT和靶区相关问题
控制率和生存率? 正常组织毒副作用
大体肿瘤区(GTV)
定义: 大体肿瘤侵犯范围和 恶性肿瘤生长部位.
GTV primary: 原发肿瘤 GTV nodal: 转移的淋巴结 GTV M: 其它转移
ICRU report 62
大体肿瘤区(GTV)
GTV的形状、大小和部位通过临床检查 (体查、内窥镜)和/或不同的影像诊断技术 (X线、CT、MRI、超声、同位素)确定。
2 Simulators
Pinnacle CMS
Nucletron
前列腺解剖和淋巴引流
膀胱 耻骨
直 肠
前列腺
调强适形和三维适形放疗
治疗体位和固定 靶区确定: GTV, CTV, PTV 正常组织的耐受剂量 模拟定位及治疗计划实施
三维适形和调强适形放疗
靶区: GTV, CTV, PTV 模拟定位及治疗计划实施 照射剂量增加能提高局部
GTV周围亚临床灶的浸润可通过显微镜检查 证实.
同一个肿瘤区(GTV)可以有两个或两个以上 临床靶区(CTV).
ICRU report 62
临床靶区 (CTV)
CTV和GTV通过静态影像确定,没 有考虑到器官运动、摆位误差及采 取的内外照射方式。
常见肿瘤靶区勾画
常见肿瘤靶区勾画 Revised by Petrel at 2021前列腺癌根治性放疗靶区建议作者:中国医学科学院肿瘤医院放疗科刘跃平李晔雄王维虎房辉来源:中国医学论坛报日期:2012-03-30随着人均寿命的延长,我国老年人口的不断增加,前列腺癌的发病率逐年上升。
放疗是前列腺癌根治性治疗手段之一,从局限低、中、高危前列腺癌到盆腔淋巴结转移,甚至远处转移前列腺癌,放疗均有广泛的应用。
对于局限期前列腺癌,放疗可取得与手术相当的疗效且并发症的发生较少。
近年来,随着各种放疗新技术的出现和发展,前列腺癌的放疗越来越准确,正常组织的保护则更可靠,因此,接受放疗的患者越来越多。
我们参照美国放疗肿瘤学研究组(RTOG)关于前列腺癌的放疗靶区勾画建议、美国国立综合癌症网络(NCCN)和欧洲泌尿协会制定的前列腺癌诊治指南,并结合我们的临床实践,对局限期前列腺癌根治性放疗的靶区勾画提出参考性建议,旨在使前列腺癌放疗靶区定义规范化和合理化。
从表1得知,前列腺癌靶区勾画主要包括前列腺、精囊腺及盆腔淋巴引流区,对局限期前列腺癌根治性放疗的靶区确定,我们提出如下建议。
1CT定位及放疗·定位前时排空膀胱和直肠,口服1000ml稀释的肠道对比剂,然后憋尿充盈膀胱。
CT定位采取仰卧位,体模固定,层厚3mm扫描,扫描范围从腰4椎体下缘至坐骨结节下3cm。
·建议采用3D-CRT或IMRT,若放疗剂量≥78Gy,建议使用图像引导放疗(IGRT)。
2前列腺及精囊腺靶区勾画·局限低危前列腺癌放疗靶区只包括前列腺;局限中危前列腺癌或盆腔淋巴结转移几率≤15%的局限高危前列腺癌放疗靶区包括前列腺和精囊腺。
·前列腺癌往往为多发灶,且CT和磁共振成像(MRI)无法检测出前列腺内的全部病灶,因此,前列腺癌难以勾画大体靶区(GTV,转移淋巴结除外),我们只勾画临床靶区(CTV)(图1)。
·前列腺靶区勾画自前列腺底至前列腺尖的全部前列腺组织(图1),若前列腺存在钙化,须包全全部钙化区域。
前列腺癌靶区勾画概要
本研究仅对了一定数量的患者进行了研究,样本量相对较小。未来可以通过扩大样本量,对更多患者进行深入研究,验证 本研究结论的可靠性。
探索前列腺癌靶区勾画技术的个性化应用
不同前列腺癌患者的肿瘤生物学特性可能存在差异,因此需要对每个患者进行个性化的靶区勾画。未来可以探索利用人工 智能等技术,实现前列腺癌靶区勾画技术的自动化和个性化应用。
图像处理与软件应用
利用相关的图像处理软件和技术,对医学影像资 料进行处理和分析,初步确定肿瘤的位置和范围 。
靶区验证与调整
完成初步靶区勾画后,需要通过医学影像学检查 对勾画的靶区进行验证和调整,以确保靶区的准 确性和合理性。
03
前列腺癌靶区勾画技术
图像融合技术
MRI与CT图像融合
将MRI与CT图像进行融合,以获得更具辨识度的靶区形状和位置。
建立完善的标准操作流程,以确 保所有参与勾画的人员都按照相 同的标准进行操作。
图像质量评估与选择
对所有用于靶区勾画的图像进行 质量评估,以确保图像清晰、分 辨率高,适合用于靶区勾画。
定期质量检查与审核
定期对勾画出的靶区进行质量检 查与审核,发现并纠正问题,不 断提高勾画质量。
勾画质量的培训课程
培训课程设计
针对不同水平的勾画人员,设计不同难度的培训课程,以确保培训内容与实际工作紧密相 关。
培训周期与考核
确定培训周期和考核标准,对参与培训的人员进行严格的考核与评估,确保培训效果达标 。
培训反馈与改进
根据培训过程中的反馈和考核结果,及时改进培训计划和内容,以提高培训效果和勾画质 量。
05
前列腺癌靶区勾画的挑战与解决方案
高放疗效果。
保护正常组织
03
前列腺癌靶区勾画概要
靶区勾画的注意事项
保持勾画的规范性和一致性
为确保治疗的准确性和可比性,应在遵循相关指南和共识的基础 上,保持靶区勾画的规范性和一致性。
充分考虑患者的个体差异
由于患者的个体差异(如体型、组织结构等),靶区勾画需充分考 虑这些因素,以制定个性化的治疗方案。
与治疗团队充分沟通与协作
靶区勾画是一个多学科合作的过程,需与放疗科、泌尿外科、影像 科等治疗团队充分沟通与协作,以确保治疗的顺利进行。
05
前列腺癌靶区勾画的未来发展 方向
人工智能在靶区勾画中的应用
人工智能技术
利用深度学习、机器学习等技术,辅助医生进行前列腺癌靶区的自 动勾画,提高勾画的准确性和效率。
数据训练
通过大量的影像数据和标注数据进行训练,使人工智能模型能够识 别肿瘤的位置、形状和大小,并生成准确的靶区勾画结果。
临床应用
在临床实践中,医生可以根据人工智能的辅助,对靶区进行更加精确 的勾画,从而提高放射治疗的精度和效果。
围正常组织的损伤。
图像引导
利用影像学技术,如CT、MRI等 ,在放疗过程中对肿瘤靶区进行 实时跟踪和调整,确保放疗的高
精度和准确性。
治疗效果的评估与监测
肿瘤退缩
通过定期的影像学检查, 观察肿瘤靶区的缩小程度 ,评估放疗对肿瘤的控制 效果。
症状改善
关注患者症状的改善情况 ,如疼痛、排尿困难等, 评估放疗对生活质量的影 响。
靶区勾画的流程
01
02
03
确定靶区范围
根据影像学和病理学信息 ,勾画出肿瘤及其周围组 织的范围,作为靶区的基 础。
调整靶区边界
根据肿瘤的生物学特性和 治疗需求,适当调整靶区 的边界,以确保足够的覆 盖范围。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
Open AccessOriginal ArticlePublished 07/18/2013 DOI: 10.7759/cureus.128 Copyright© 2013 Smith et al. Distributed underCreative Commons CC-BY 3.0Comparative Review of Consensus-Based Clinical T arget VolumeDefinitions for Prostate RadiotherapyGraham Smith, George RodriguesCorresponding author: George Rodrigues1. Department of Epidemiology and Biostatistics, W estern University, London ON, Canada, N6A 5C12. Department of Oncology, London Health Sciences Centre; Schulich School of Medicine & Dentistry, W estern University, London, Ontario, CA Categories: Radiation Oncology, Epidemiology & Public Health, UrologyKeywords: clinical target volume, prostate cancer, contouring, guidelines, radiation therapy, consensus guidelinesHow to cite this articleSmith G, Rodrigues G (2013-07-18 10:50:36 UTC) Comparative Review of Consensus-Based Clinical T arget V olume Definitions for Prostate Radiotherapy. Cureus 5(7): e128. doi:10.7759/cureus.128AbstractBackground: A major obstacle in the delivery of postoperativeradiation therapy (RT) for prostate cancer is accurate delineation of the tumor targets and organs at risk. Although postoperative prostate cancer contouring atlases are quite common, there is still no widely accepted contouring guideline. The purpose of this study is to critically review the various postoperative prostate RT treatment planning consensus guidelines or atlases currently available.Methods: A literature search was conducted using various electronic databases with the key terms: prostate, contour, planning tumour volume, clinical target volume, delineation or definition, guidelines or atlas, and radiation oncology. The search was limited to English publications from the years 1985 to 2011.Results: A total of seven publications relating to contouring guidelinesfor postoperative prostate radiotherapy were identified. There are four distinct consensus guidelines developed by major institutions: Princess Margaret Hospital, the Australian and New Zealand RadiationOncology Genito-Urinary Group, the European Organization for Research and Treatment of Cancer, and the Radiation TherapyOncology Group.Conclusions: After reviewing the consensus contouring guidelines for postoperative prostate cancer radiation therapy that were available inthe literature, it is clear that there disagreement with regards to what anatomical borders should be used for delineating an appropriateprostate bed CTV. Additional studies comparing the reproducibility ofthe various guidelines as well as the performance of these guidelines onclinically important outcomes are needed. IntroductionPostoperative radiation therapy (RT) is indicated in the treatment of post-prostatectomy patients with high-risk of local recurrence [1]. Recent studies have shown RT to be beneficial following radical prostatectomy in both the adjuvant setting, for patients with high-risk pathological features, such as positive surgical margins and seminal vesicle invasion [2-8], or as salvage for biochemical disease recurrence [9-10]. Two randomised controlled trials suggest adjuvant RT directly following surgery provides improved progression-free survival, biochemical relapse-free survival, and local control over watchful waiting protocols [3, 11]. Although a long-term follow-up of one of these trials also suggests that adjuvant RT also improves metastasis-free survival and overall survival compared with observation alone [2], there is insufficient long-term follow-up data available to adequately assess the effect on these treatment outcomes.A major obstacle in the delivery of postoperative radiation therapyfor prostate cancer is accurate delineation of the tumor targets and Organs at Risk (OARs). Inter-observer variability between oncologist drawn contours in prostate radiation therapy is well documented [12-15] and has been identified as a highly significant contributing factor to uncertainty in radiation therapy treatment planning [16]. Contouring consensus guidelines or atlases for postoperative prostate RT have been created to aid oncologists in the delineationof tumor targets and OARs with the hope of reducing this variability.Although postoperative prostate cancer contouring atlases are quite common, there is still no widely accepted contouring guideline. The purpose of this study is to critically review the various postoperative prostate RT treatment planning consensus guidelines or atlases currently available with emphases on the methodology and validity of each atlas.Materials And MethodsA literature search was conducted using the electronic databases Pubmed, MEDLINE (OVID), EMBASE, Cochrane Library, and Google Scholar with the key terms: prostate, contour, planning tumourScholar with the key terms: prostate, contour, planning tumour volume, clinical target volume, delineation or definition, guidelines or atlas, and radiation oncology. The search was limited to English publications from the years 1985 to 2011. Relevant studies found on references lists of identified articles were included as well as any articles found on national cooperative group websites, including the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC). Only studies related to medicine or physics (including radiation oncology, imaging, oncology or cancer) were included. The methodology used in these articles including how each consensus was reached and study validity was reviewed, and any similarities and differences found in the contouring guidelines were detailed.ResultsLiterature SearchA total of seven publications relating to contouring guidelines for postoperative prostate radiotherapy were identified [17-23]. There are four distinct consensus guidelines developed by major institutions: Princess Margaret Hospital (PMH) [17], the Australian and New Zealand Radiation Oncology Genito-Urinary Group (FROGG) [19], the European Organization for Research and Treatment of Cancer (EORTC) [21], and the Radiation Therapy Oncology Group (RTOG) [22]. A fifth consensus statement was identified from the Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) group in their validation study [18], in which they used a modified version of the PMH consensus guideline. No publication outlining the contents of this version was found. There were five studies discussing the methodology used in the creation of the various consensus statements [17, 19, 21-23]. The information from the EORTC consensus was published in two separate articles [21, 23]. There were two validation publications, one from the RADICALS [18] and the other from EORTC [20]. The study by PMH [17] contains both a description of how their consensus was reached as well as a validation component. Although the article from Boehmer, et al. [23] was on guidelines for radiotherapy for intact prostate, it was referred to in the EORTC consensus for postoperative prostate radiotherapy by Poortman, et al. [21] and was included in this review. The studies were published between 2006 and 2011 and represent a large number of medical institutions from a wide range of countries (Table 1).Primary Oncology Number of ConsensusPrimary Author Group/InstitutionResponsible forConsensusCountries InvolvedDatePublishedMedicalInstitutionsInvolved[C] and/orValidation[V] StudyK. Wiltshire PMHAustralia, Canada,Switzerland20074C, VD. MitchellRADICALS United Kingdom20092VM. Sidhom FROGG-RANZCR Australia,Singapore, NewZealand20087CP. Ost EORTC Belgium20111VP. Poortmans EORTCBelgium, France,Germany,Netherlands,Switzerland, UnitedKingdom200713CJ.MichalskiRTOG Canada, USA201013CD. Boehmer*EORTCBelgium, France,Germany,Netherlands,Switzerland, UnitedKingdom200610CT able 1: Post-operative prostate radiation therapy contouring consensus guideline publicationsAbbreviations: PMH = Princess Margaret Hospital; RADICALS = Radiotherapy andAndrogen Deprivation In Combination After Local Surgery; EORTC = European Organization for Research and T reatment of Cancer; RTOG = Radiation Therapy Oncology Group;FROGG-RANZCR = The Faculty of Radiation Oncology Genito-Urinary Group part of theRoyal Australian and New Zealand College of Radiologists. * European Organization for Research and T reatment of Cancer consensus guidelines for intact prostateDiscussionConsensus MethodologyThe methodology for creating the consensus atlases by the RTOG, FROGG and PMH began with delineation of preliminary contours by a small group of clinicians, involving at least one oncologist or urologist experienced with postoperative prostate radiotherapy or prostatectomy [17, 19, 22]. In these studies, the clinicians responsible for delineating the initial contours were given patients with specific clinical scenarios and were asked to delineate an appropriate clinical target volume (CTV) based on their expert knowledge of anatomy, tumor physiology and patterns of spread [17,19, 22]. Consensus guidelines from the RTOG, FROGG and PMH were finalized following a presentation and discussion of their preliminary contours at a conference or consensus workshop [17, 19, 22]. Inter-professional collaboration between diverse multi-disciplinary groups of health care professionals, specifically individuals with expertise in the treatment of prostate cancer, was utilized in the creation of the consensus atlases [17, 19, 21-23]. The study by PMH focused on postoperative prostate patients with or without seminal vesicle invasion [17], while the RTOG study focused on the clinical scenarios of seminal vesicle invasion and positive apex margins [22]. A review of relevant literature was present in the development of each of the consensus guidelines [17, 19, 21-23].The initial contours generated by PMH were presented at the Australian Faculty of Radiation Oncology Genito-Urinary Oncology Group Consensus Workshop on Post-Prostatectomy Radiotherapy in June 2006 [17, 19]. The consensus guidelines created at this conference were further modified by the FROGG and were used in the creation of their own consensus atlas [19].The RTOG used an imputation method of the expected maximum (EM) algorithms for simultaneous truth and performance level estimation (STAPLE) [24] to create their preliminary contours. The STAPLE algorithm has been previously identified as a useful tool in analyzing expert radiation oncologist consensus contours [25]. The RTOG STAPLE contours were presented at a RTOG conference where they were discussed and a consensus was finalized following a teleconference [22].There was no information given by the EORTC regarding the exact process in which their consensus guideline was reached. Instead, the EORTC presents detailed manuscripts reviewing published works relevant to prostate cancer, specifically studies on surgery, anatomy and local recurrence [21, 23].A detailed description of the methods involved in the creation of the four contouring guidelines is shown in Table 2.Consensus How Consensus was ReachedThree urologists experienced with open or laparoscopic prostatectomyindependently delineated the anatomical borders of the prostate bed atrisk of microscopic cancer seeding on axial MRI scans of 2 patients(with and without seminal vesicles, selected randomly from the patientpopulation) and presented these contours to a multi-disciplinary Genito-Wiltshire et al (PMH)Urinary (GU) tumor board. An Interdisciplinary discussion between all members of the GU board including radiation oncologists, medical oncologists, urologists, uroradiologists and uropathologists occurred and a review of the literature (patterns of failure, surgical practice, radiologic anatomy) was completed. Final consensus CTV was defined by 1 uroradiologist and 2 radiation oncologists and was approved by a GU board containing 10 rad oncologists, 4 urologists and 1 uroradiologist. Consensus was modified further following presentations of consensus at Australian Faculty of Radiation Oncology Genito-Urinary Oncology Group Consensus Workshop on Post Prostatectomy Radiotherapy June 2006 and Genito-Urinary Radiation Oncologists of Canada Meeting January 2007.FROGG-RANZCR Consensus was reached following a 2-day consensus workshop. Prior to workshop extensive literature review was performed which led FROGG executives to generate a draft of post-prostatectomy guidelines.Guidelines from PMH were presented at the conference, discussed and refined. Expert speakers from radiation oncology, urology and radiology presented data on topics relevant to post-prostatectomy radiotherapy at 2-day workshop. 63 delegates from Radiation Oncology, Radiology, Urology, Medical Physics, and Radiation Therapy attended. Unresolved issues handled by workshop parties for final revisionRTOG 11 oncologist observers contoured 2 post-op prostate patients with 2 separate clinical scenario cases: 1) positive apex margin or 2) invasion of seminal vesicles and evaluated the inter-observer variability between oncologists (each oncologist was to use their own institution's contouring policy). From these contours they used an imputation method of the expected maximum (EM) algorithms for simultaneous truth and performance level estimation (STAPLE), to create a consensus contour derived from the collection of observer contours. The STAPLE contour represents the 'true' contour for each patient. The RTOG held a conference where they presented a review of patterns of failure, anatomy and surgical findings related to radical prostatectomy. Each STAPLE contour (for each patient case) was used as a starting point for discussion and creation of consensus guidelines. The RTOG reviewed and modified the consensus contours at a conference and finalized them via teleconference.EORTC Presented a manuscript reviewing published work on local recurrence sites in post-op prostate cancer, surgery and anatomy. It is unclear as to how their consensus was reached.T able 2: Description of consensus guideline methodologyAbbreviations: PMH = Princess Margaret Hospital; RADICALS = Radiotherapy and Androgen Deprivation In Combination After Local Surgery; EORTC = European Organization for Research and T reatment of Cancer; RTOG = Radiation Therapy Oncology Group;FROGG-RANZCR = The Faculty of Radiation Oncology Genito-Urinary Group part of the Royal Australian and New Zealand College of Radiologists.Validation StudiesThere were three publications validating consensus guidelines for postoperative prostate radiotherapy found in the literature [17-18, 20]. Consensus statements from the EORTC, PMH as well as amodified version of the PMH consensus (RADICALS) were evaluated in these studies [17-18, 20]. There were no validation studies found from the RTOG or the FROGG. A summary of the validation studies is presented in Table 3.Author (Country)ConsensusValidatedStudyPopulation(#Patients)Health CareProfessionalsInvolved (#)Description ResultsWiltshireet al (Canada)PMHStudy 1)25Study 2)16Study 3)20Study 1) 3oncologistobservers.Study 2) 2oncologistobservers.Study 3) Noinformationgiven.Study 1)Assessingconsensus CTVcoverage usingprostate bedsurgical clips.Study 2) Intra-and inter-observervariability studyto determinereproducibility ofconsensus.Study 3)Retrospectivestudy todetermine theimpact of theconsensusguidelines onclinical practiceusing dosevolumehistograms.Study 1) Surgical clipswell distributed, with alower clip densityappreciated at anterior-superior and posterior-most extent of CTV.Surgical Clips werecontained (338 out of339 clips) withinconsensus CTV.Study 2) Smallsystematic inter-observererrors were observed inthe AP dimension. Mostuncertainty wasobserved insuperior/posterior/lateralaspect of CTV. Intra- andinter-observer variabilitywas described asrandom and notsystemic.Study 3) CTV volumeand field size increasedwith consensus. Lessthat 50% of patientsreceived prescribedmicroscopic dose (V100>95%)Mitchellet al (United Kingdom) *RADICALS36 sitespecializedobservers.Compared CTVsizes before andafter contouringguideline use.Inter-observervariability studyto compareobservercontours usingthe coefficient ofvariationstatisticalmethod. Acomparison usingMaximumVolume Ratio(MVR) todetermine thegreatest extent ofdifferencebetween thevolumes beforeand after the useof guidelines wasmade.CTV increased in sizewith reduced inter-observer variability intreatment plan contoursOst et al (Belgium)EORTC101 radiologistand 5radiationoncologistobservers.Inter-observervariability study.Volumes werecompared usingan open-sourceMatlab-basedradiation therapyplanning analysisstatistical tool foragreement(apparent volumeof overlapcorrected usingkappa statistics)to determine ifEORTCguidelinesGuidelines showmoderate inter-observeragreement (mean kappa,0.49) and refinement ofEORTC guidelines wererecommended.reduced variationin contours.T able 3: Consensus Guideline Validation StudiesAbbreviations: PMH = Princess Margaret Hospital; RADICALS = Radiotherapy andAndrogen Deprivation In Combination After Local Surgery; EORTC = European Organization for Research and T reatment of Cancer; CTV = Clinical T arget Volume. * Modified Princess Margaret Hospital consensus guidelines.The publication from PMH validates their consensus in three separate studies [17].The first validation study assessed the coverage of the consensus Clinical Target Volume (CTV) relative to prostate bed surgical clips placed during routine clinical practice at their institution. There were 25 postoperative prostate patients with a total of 339 surgical clips in the entire patient cohort. A single observer was responsible for delineating an appropriate CTV for each patient using the PMH consensus guidelines, while a second observer was responsible for identifying the surgical clip co-ordinates on CT scans for each patient [17]. To visualize how well the surgical clips were contained within the consensus contours deformable registration and a finite element modeling (FEM) method, (Mofeus), [26] was used to generate a single CTV representing the entire cohort to evaluate its coverage of the surgical clips [17]. Results showed all surgical clips were contained within the consensus CTV, minus one outlier, and the distribution throughout the CTV was uniformly observed, with a lower clip density appreciated at the anterior-superior and posterior-most aspects [17].The second validation looked at the intra- and inter-observer reproducibility of the consensus contours. Two observers individually contoured 16 patients on MRI and CT scans and repeated this at least one week later [17]. The reproducibility of the contours was assessed using the finite element modeling (FEM) method, Morfeus, statistical tool used previously in their first validation study [26]. The variation in observer contours were said to be “mainly random” with small systematic inter-observer errors observed in the Anterior-Posterior (AP) dimension [17].The third PMH validation study involved a retrospective analysis of the effects of the consensus guidelines on clinical practice. Twenty patients previously treated with various techniques of postoperative radiotherapy (including one or two phase four-field box or IntensityModulated Radiation Therapy) were re-planned using the PMH consensus guidelines. The newly created plans were compared both volumetrically and dosimetrically to the original plans used for treatment. An increase in both the contour volumes and field sizes was observed in the consensus plans and only 50% of the patients would have received the prescribed microscopic dose (V100 >95%) to the CTV in these plans [17].The validation study by Ost, et al. assessed whether adopting the EORTC consensus guidelines would reduce inter-observer contouring variability at their institution. Ost, et al. compared the contours of 10 patients, delineated by six observers (five radiation oncologists and one radiologist) using the EORTC guidelines [20]. The variability was assessed using an open-source Matlab-based radiation therapy planning analysis statistical tool [27] for agreement (volume of overlap corrected using kappa statistics) [28]. The specificity and sensitivity of the observer contours with and without the contouring guidelines was evaluated using the STAPLE method [24]. Variation in dimensions of observer contours in the superior, inferior, anterior, posterior, and lateral margins were assed by comparing the distances of the outer margins of each CTV to a pre-determined centre point [20]. The inferior margin variability was assed by comparing the inferior border distance to the penile bulb delineated on MRI. Ost, et al. described the overall inter-observer agreement for the CTVs using the EORTC guidelines as moderate (mean kappa,0.49), and recommended a refinement of the EORTC consensus atlas [20].The modified PMH consensus guidelines assessed by Mitchell, et al. on behalf of the RADICALS were not defined in their study or foundin the literature. Mitchell, et al. found that using the RADICALS consensus guidelines led to an increase in the volume of the CTV and there was a reduction in inter-observer variability [18].T arget Volume DefinitionsThe consensus information regarding the margins adopted by each institution is displayed in Table 4. Consensus statements from PMH, FROGG and the RTOG focused on border landmarks in their consensus [17, 19, 22], while the EORTC included areas at greatest risk for relapse in their CTV guidelines [21, 23].ConsensusSuperior Margin Inferior Margin Lateral Margin AnteriorMarginPosteriorMarginWiltshire et al (PMH) Superiorsurgical clips (ifpresent) or 5mm above theinferior borderof the vasdeferens.Include seminalvesicles whenpathologicallyinvolved.8mm belowVUA or top ofPenile Bulb (PB)(whichever ismost superior).Medial boarder oflevator ani andobturator internus(caudal);Sacrorectogenitopubicfascia, lateral to theneurovascularstructures (cranial).Posterioredge ofsymphysispubis to topofsymphysispubis(caudal);Posterior1.5cm ofbladderwall(cranial).Anteriorrectal wallandlevator ani(caudal);Mesorectalfascia(cranial).FROGG-RANZCR Encompass allof the seminalvesicle bed asdefined by non-vascular clipsand shouldinclude thedistal portion ofthe vas deferens.Include seminalvesicles ifpathologicallyinvolved.5–6 mm belowthevesicourethralanastomosis(extended lowerto include allsurgical clips).When VUA ispoorly definedINF border willbe the sliceabove the penilebulb.The medial border ofthe levator ani orobturator internus.Posterioredge ofsymphysispubis(caudal);Posterior1.5 cm ofthe bladder(cranial).Anteriorrectal wallandlevator ani(caudal);Anteriormesorectalfascia(cranial).EORTC Bladder neckand up to baseof seminalvesicles Includeseminal vesiclesif pathologicallyinvolved.15 mm craniallyfrom the penilebulb or at theapex.Include up to theneurovascular bundles(if removed up to theilio-obturatic muscles).Includeanastomosisand theurethralaxis.Up to butnotincludingthe outerrectal wall(caudal);Mostposteriorpart of thebladder(cranial).Level of cut endof vas deferensor 3–4 cm abovetop of symphysis(Vas may retract8–12 mm belowvesicourethralanastomosis(May includemore if concernfor apicalLevator ani andobturator internus(caudal);SacrorectogenitopubicPosterioredge ofpubic bone(caudal);Anteriorrectal wall(caudal) -May needto beconcaveRTOG (Vas may retractpostoperatively).Include seminalvesicle ifpathologicallyinvolved.margin). Canextend to sliceabove penilebulb ifvesicourethralanastomosis notwell visualized.fascia (cranial). Ifconcern aboutextraprostatic diseaseat base may extend toobturator internus.(caudal);Post 1-2 cmof bladderwall(cranial).concavearoundlateralaspects;Mesorectalfascia(cranial).T able 4: CTV margin recommendations from consensus guideline atlases Abbreviations: PMH = Princess Margaret Hospital; EORTC = European Organization for Research and T reatment of Cancer; RTOG = Radiation Therapy Oncology Group; FROGG-RANZCR = The Faculty of Radiation Oncology Genito-Urinary Group part of the Royal Australian and New Zealand College of Radiologists.Superior Margin:The anatomical landmarks used as the superior boundary in the consensus statements were the level of the cut end of the vas deferens [17, 19, 22] or the bladder neck up to the base of the seminal vesicles [21]. The superiorly located prostate bed surgical clips were included in the superior margin by PMH and FROGG [17, 19]. PMH recommends a 5mm margin above the vas deferens as an alternative superior margin in the absence of surgical clips or when the vas deferens is poorly visualized [17]. If the vas deferens retracts posteriorly, the RTOG suggests using a superior margin 3-4 cm above the top of the pubic symphysis [22]. The EORTC recommends the bladder neck up to the base of the seminal vesicles be included inthe prostate bed CTV [21].Inferior Margin:There were two methods used to delineate the inferior border in the consensus guidelines, involving either a designated distance below the vesicourethral anastomosis (VUA) [17, 19, 22], or slightly above the penile bulb or at the apex [21]. The measurements chosen for the distance below the VUA ranged from 5-6 mm [19] to 8-12mm [22]. The penile bulb was chosen as an alternative landmark for defining the inferior border by PMH, FROGG and the RTOG in the event that the VUA is poorly visualized [17, 19, 22].Lateral Margin:The lateral margin chosen by PMH, FROGG and the RTOG was the levator ani and obturator muscles (caudally), and the Sacrorectogenitopubic fascia (cranially) [17, 19, 22]. The EORTCchose the neurovascular bundles as their lateral border [21].Anterior Margin:The anterior margin chosen by PMH, FROGG and the RTOG was the posterior edge of the pubic symphysis (caudally) and the posterior bladder wall (cranially) [17, 19, 22]. The anterior margin from the EORTC includes the anastomosis and the urethral axis [21].Posterior Margin:All four institutions chose the anterior rectal wall for the posterior, caudal border [17, 19, 21-22]. The mesorectal fascia was chosen by PMH, FROGG and the RTOG for the posterior cranial border [17, 19, 22], while the EORTC chose the posterior bladder [21]. Additional Consensus InformationInformation regarding the imaging technology, patient positioning, vesicourethral anastomosis (VUA) visualization method, organs at risk (OARs), and additional target volume recommendations from the consensus guidelines are displayed in Table 5.Consensus ImagingTechnologyPatientPositioningand OrganPrepVUAVisualizationMethodOARsAdditional CTV andPTVrecommendationsWiltshire et al (PMH)Axial, pelvic,helical CT (2mmthickness with nocontrast) andMRI used increation ofconsensus; Useof multi-slice CTscanning withMRIrecommended.Patientpositionedsupine withcustomVac-Lokdevice;Bladdercomfortablyfull; Emptyrectum (wMilk ofmagnesia.Sagittal CTNotDiscussedCTV: Extended toinclude 1 cmbeyond the grossrecurrent disease,and visible surgicalclips locatedoutsideboundaries,excluding highlymphadenectomyvessel clips.PTV: Aroundsuperior (cranial)CTV: 15 mmsuperior-inferior[SI] and anterior-posterior [AP] and12 mm right–left。